Phase II - HCC Biomarker Study
The goal of the HCC Biomarker study is to develop a diagnostic blood test that can identify liver cancer in its early stages and predict liver cancer recurrence after surgical resection.
Is this Research Study for You?
Study participants should be at least 18 years of age and fall into one of the following categories:
- Liver cancer subjects who have not received treatment in the past year, or
- Subjects recently diagnosed with either liver cirrhosis, hepatitis B or C, or pancreatitis, or
- Healthy subjects with none of the previously listed conditions
How the Study Works
If you qualify for and choose to participate in this study, your participation will include a one-time blood draw. There is no further follow-up needed on your part.
Location of the Research Study
Drexel Surgery Center City
Drexel University at Hahnemann University Hospital
Broad and Vine Streets
Philadelphia, PA 19102
Contact us today for more information!
Principal Investigator: Gary Xiao, MD*
* Physician's practice/location is independent of Drexel Medicine and Drexel University.
The information on these pages is provided for general information only and should not be used for diagnosis or treatment, or as a substitute for consultation with a physician or health care professional. If you have specific questions or concerns about your health, you should consult your health care professional.
The images being used are for illustrative purposes only; any person depicted is a model.
Back to Top